Drug Hunter is a subscription service catering to R&D-focused organizations in the field of drug discovery. The company aims to consolidate the fragmented knowledge of drug discovery strategies, tactics, challenges, and solutions from various sources into a searchable platform. Founded in 2018 by a team of industry scientists, Drug Hunter currently serves over 150 institutions worldwide, including leading pharma and biotech companies, investors, and non-profits. The platform focuses on Biotechnology, Data Analytics, Health Care, Life Sciences, and Platforms. Drug Hunter's mission is to provide industry-specific insights to facilitate better decision-making and address critical discovery challenges. For more information, visit drughunter.com.
There is no investment information
No recent news or press coverage available for Drug Hunter.